Personalis Return on Investment 2018-2024 | PSNL
Current and historical return on investment (ROI) values for Personalis (PSNL) over the last 10 years.
| Personalis ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-06-30 |
$-0.09B |
|
inf% |
| 2024-03-31 |
$-0.10B |
|
inf% |
| 2023-12-31 |
$-0.11B |
|
inf% |
| 2023-09-30 |
$-0.12B |
|
inf% |
| 2023-06-30 |
$-0.11B |
|
inf% |
| 2023-03-31 |
$-0.12B |
|
inf% |
| 2022-12-31 |
$-0.12B |
|
inf% |
| 2022-09-30 |
$-0.10B |
|
inf% |
| 2022-06-30 |
$-0.09B |
|
inf% |
| 2022-03-31 |
$-0.08B |
|
inf% |
| 2021-12-31 |
$-0.07B |
|
inf% |
| 2021-09-30 |
$-0.06B |
|
inf% |
| 2021-06-30 |
$-0.05B |
|
inf% |
| 2021-03-31 |
$-0.04B |
|
inf% |
| 2020-12-31 |
$-0.04B |
|
inf% |
| 2020-09-30 |
$-0.04B |
|
inf% |
| 2020-06-30 |
$-0.03B |
|
inf% |
| 2020-03-31 |
$-0.03B |
|
-80.00% |
| 2019-12-31 |
$-0.02B |
|
-65.19% |
| 2019-06-30 |
$-0.01B |
$0.14B |
-32.59% |
| 2019-03-31 |
$-0.01B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.270B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
